Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDBioNTech SE Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 4 | -$1.95 | -$0.92 | -$1.44 |
| Q2 2026 | 1 | -$2.57 | -$0.81 | -$1.73 |
| Q3 2026 | 1 | -$0.59 | -$0.19 | -$0.40 |
| Q4 2026 | 1 | $0.44 | $1.40 | $0.94 |
BioNTech SE Earnings Date And Information
BioNTech SE last posted its earnings results on Monday, November 3rd, 2025. The company reported $-0.14 earnings per share for the quarter, missing analysts' consensus estimates of $0.75 by $0.89. The company had revenue of 1.52 B for the quarter and had revenue of 2.75 B for the year. BioNTech SE has generated $-3 earnings per share over the last year ($-2.77 diluted earnings per share) and currently has a price-to-earnings ratio of -37.99. BioNTech SE has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
BioNTech SE Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/03/2025 | Q3 2025 | $0.75 | -$0.12 | -0.87 | $843.68 M | $1.52 B |
| 08/04/2025 | Q2 2025 | -$1.31 | -$1.60 | -0.29 | $177.80 M | $260.80 M |
| 03/31/2025 | Q1 2025 | N/A | -$1.73 | N/A | N/A | $182.80 M |
| 12/31/2024 | Q4 2024 | N/A | $1.08 | N/A | N/A | $1.19 B |
| 09/28/2024 | Q3 2024 | N/A | $0.83 | N/A | $572.38 M | $1.24 B |
| 06/28/2024 | Q2 2024 | N/A | -$3.42 | N/A | $145.36 M | $128.70 M |
| 03/30/2024 | Q1 2024 | N/A | -$1.31 | N/A | N/A | $187.60 M |
| 12/30/2023 | Q4 2023 | N/A | $1.88 | N/A | N/A | $1.48 B |
| 09/29/2023 | Q3 2023 | N/A | $0.69 | N/A | N/A | $895.30 M |
| 06/29/2023 | Q2 2023 | N/A | -$0.79 | N/A | N/A | $167.70 M |
| 03/31/2023 | Q1 2023 | N/A | $2.05 | N/A | N/A | $1.28 B |
| 12/31/2022 | Q4 2022 | N/A | $8.94 | N/A | N/A | $4.28 B |
| 09/30/2022 | Q3 2022 | N/A | $6.98 | N/A | N/A | $3.46 B |
| 06/30/2022 | Q2 2022 | N/A | $6.45 | N/A | N/A | $3.20 B |
| 03/31/2022 | Q1 2022 | N/A | $14.24 | N/A | N/A | $6.37 B |
| 12/31/2021 | Q4 2021 | N/A | $12.95 | N/A | N/A | $5.53 B |
| 09/30/2021 | Q3 2021 | N/A | $13.14 | N/A | N/A | $6.09 B |
| 06/30/2021 | Q2 2021 | N/A | $11.42 | N/A | N/A | $5.31 B |
| 03/31/2021 | Q1 2021 | N/A | $4.64 | N/A | N/A | $2.05 B |
| 12/31/2020 | Q4 2020 | N/A | $1.55 | N/A | N/A | $345.44 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
BioNTech SE Earnings: FAQ's
The conference call for BioNTech SE's latest earnings report can be listened to online.
The conference call transcript for BioNTech SE's latest earnings report can be read online.
BioNTech SE (:BNTX) has a recorded annual revenue of $2.75 B.
BioNTech SE (:BNTX) has a recorded net income of $-665,300,000.BioNTech SE has generated $-2.77 earnings per share over the last four quarters.
BioNTech SE (:BNTX) has a price-to-earnings ratio of -37.99 and price/earnings-to-growth ratio is 0.57.